Hepatocellular Carcinoma (HCC)
Péter Ferenci, Anton Le Mair(University Hospital of Zurich), Masao Omata(The University of Tokyo), Aamir Ali Khan(Hospital Clínic de Barcelona), Peter Malfertheiner(Ludwig-Maximilians-Universität München), J A Otegbayo(University of Iowa Health Care), Morris Sherman(Nihon University), Salma Barakat Modawi(Toronto Western Hospital), Justus Krabshuis(Medical University of Vienna), Teehra Piratsivuth(Medical University of Vienna), Mike Kew(University of Cape Town), Jordi Bruix(Universitat de Barcelona), George Lau(University of Hong Kong), Shi Zheng(Zhejiang University), Alan Thomson(University of Iowa Health Care), S S Fedail(University of Khartoum), Michael Fried(University Hospital of Zurich), Wolfgang E. Fleig(Mayo Clinic), Flair J. Carillo(Toronto Western Hospital), Jenny Heathcote(Toronto Western Hospital), Saket Sarin(University Health Network), Douglas R. LaBrecque(University of Iowa Health Care), Saeed Hamid(Aga Khan University)
Cited by 322
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k